Skip to Content
Merck
  • Derivatised alpha-tocopherol as a CoQ10 carrier in a novel water-soluble formulation.

Derivatised alpha-tocopherol as a CoQ10 carrier in a novel water-soluble formulation.

BioFactors (Oxford, England) (2003-12-30)
Marianna Sikorska, Henryk Borowy-Borowski, Bogdan Zurakowski, P Roy Walker
ABSTRACT

We have derivatised alpha-tocopherol (vitamin E) to a water-soluble polyoxyethanyl-alpha - tocopheryl sebacate (PTS) and discovered that it formed a non-covalent complex with CoQ10 at a molar ratio of 2:1 (PTS-CoQ10). This complex was water-soluble and remained stable for extended periods of time. After oral delivery of the formulation into rats PTS was hydrolysed to vitamin E and elevated levels of both vitamin E and CoQ10 in blood plasma were detected within 1 h. Thus, this aqueous formulation contains a combination of two potent antioxidants. The formulation's efficacy was tested against ischemic brain damage caused by a transient (8 min) bilateral occlusion of the common carotid arteries in rats. The animals received PTS-CoQ10 by two intraperitoneal injections given immediately after ischemia and 3 h later and the brain damage was assessed up to 12 days post-ischemia. A significant neuroprotection was observed in the CA1 hippocampal region, for example at 12 days approximately 50% of CA1 neurons were still alive in the treated animals versus less than 5% in the non-treated group. Our data is consistent with previously published observations indicating the therapeutic potential of antioxidants for treatments of ischemia/reperfusion injuries and the formulation described here is particularly appropriate for the application in acute conditions, such as stroke or cardiac arrest.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sebacoyl chloride, 99%
Sigma-Aldrich
Sebacoyl chloride, technical grade, 92%
Sigma-Aldrich
Sebacoyl chloride, purum, ≥95.0% (GC)